The Food and Drug Administration’s approval of the abortion drug RU-486 sparked a new round of debate between pro-life and pro-choice activists, but it also brought forth a new discussion about the drug’s medical benefits and drawbacks, who will be allowed to administer it, and how states will regulate its use. A panel talks about the new concerns raised by the introduction of RU-486 in the U.S.


  • Maxine Klane Planned Parenthood of Metropolitan Washington
  • Dr. Mitchell Creinin Physician
  • Richard Pierce Professor of administrative law at George Washington University

Related Links

Topics + Tags


comments powered by Disqus
Most Recent Shows